The US Food and Drug Administration (FDA) is strengthening existing warnings about serious behavior and mood-related changes with montelukast (Singulair; Merck and generics), which is used to treat ...

(CNN) --The US Food and Drug Administration announced Wednesday it is requiring a boxed warning -- the agency's most prominent warning -- for asthma and allergy medication montelukast, sold under the ...

Montelukast (as sodium) 4mg, 5mg; tabs; cherry flavor; contains phenylalanine. Take granules by mouth within 15mins of opening packet; may dissolve in 5mL of cold or room temperature baby formula or ...

Montelukast (Singulair) held no elevated risk of depression, anxiety, suicidality, or behavioral problems for children, according to a new study that throws further doubt on the black box warning over ...

Some asthma and allergy medication will now require a stronger warning label, the U.S. Food and Drug Administration announced Wednesday. The medication, generically known as montelukast, but sold ...

A Boxed Warning or “Black Box Warning,” the most prominent and serious of FDA warnings about prescription drugs, will adorn packages of asthma and allergy medicine montelukast (brand name: Singulair), ...

U.S. government researchers have found that a widely prescribed asthma drug originally sold by Merck & Co may be linked to serious mental health problems for some patients, according to a scientific ...

My husband was prescribed Singulair by his allergist and took it for two years. At the end of that time, he was diagnosed with depression and memory loss. His neurologist advised that he shouldn’t ...

The Food and Drug Administration is issuing a boxed warning — its strongest warning — for a widely prescribed asthma and allergy drug, citing its potential to cause "serious behavior and mood-related ...

Feb. 14, 2003 — Montelukast is effective in treating bronchiolitis which develops after respiratory syncytial virus (RSV) infection, according to the results of a randomized, double-blind trial ...

One form of montelukast, a medication commonly prescribed to treat asthma symptoms, has been voluntarily recalled for a potentially dangerous labeling mix-up, according to a statement from the Food ...